NCT05886218Recruiting

Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

University of California, Davis

Start Date

2/8/2023

Completion Date

7/1/2025

Summary

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * age greater than 18 years * scheduled for an elective laparoscopic gastric bypass procedure Exclusion Criteria: * age less than 18 years * pregnancy * prisoners * significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication * patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2\>98%)

Interventions

DEVICE

Quantitative Neuromuscular Function Monitoring

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Sugammadex

Locations

UC Davis Medical Center

Sacramento, California 95817

United States